ask="N/A"
ask_size="N/A"
average_daily_volume="404103"
bid="N/A"
bid_size="N/A"
book_value="8.16"
change="-0.02"
change_from_200_day_moving_average="-0.30"
change_from_50_day_moving_average="-0.72"
change_from_52_week_high="-5.25"
change_From_52_week_low="7.72"
change_in_percent="-0.10%"
close="19.32"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.14"
ebitda="-16.56M"
eps_estimate_current_year="-1.32"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.11"
ex_dividend_date="N/A"
float_shares="21959000"
high="19.87"
high_52_weeks="24.57"
last_trade_date="1/6/2017"
last_trade_price="19.32"
last_trade_size="32298"
last_trade_time="4:00pm"
low="19.26"
low_52_weeks="11.60"
market_capitalization="728.98M"
moving_average_200_day="19.62"
moving_average_50_day="20.04"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="34.67"
open="19.38"
pe_ratio="N/A"
peg_ratio="-0.73"
percent_change_from_200_day_moving_average="-1.51%"
percent_change_from_50_day_moving_average="-3.61%"
percent_change_from_52_week_high="-21.37%"
percent_change_from_52_week_low="+66.55%"
previous_close="19.34"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.37"
price_per_sales="5.76"
revenue="126.71M"
shares_outstanding="37732000"
short_ratio="13.96"
stock_exchange="NGM"
symbol="RTRX"
volume="566276"
weeks_range_52="11.60 - 24.57"
